Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Psychemedics Corporation stock

Learn how to easily invest in Psychemedics Corporation stock.

Psychemedics Corporation is a diagnostics & research business based in the US. Psychemedics Corporation shares (PMD) are listed on the NASDAQ and all prices are listed in US Dollars. Psychemedics Corporation employs 138 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Psychemedics Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Psychemedics Corporation stock price (NASDAQ: PMD)

Use our graph to track the performance of PMD stocks over time.

Psychemedics Corporation shares at a glance

Information last updated 2022-01-10.
Latest market close$7.17
52-week range$4.92 - $8.84
50-day moving average $7.84
200-day moving average $7.42
Wall St. target price$32.00
PE ratio 105
Dividend yield $0 (2.65%)
Earnings per share (TTM) $0.07

Buy Psychemedics Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Psychemedics Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Psychemedics Corporation price performance over time

Historical closes compared with the close of $7.17 from 2022-01-14

1 week (2022-01-07) -5.16%
1 month (2021-12-16) 0.99%
3 months (2021-10-15) -14.23%
6 months (2021-07-16) 5.29%
1 year (2021-01-15) 44.85%
2 years (2020-01-16) -32.49%
3 years (2019-01-16) 18.04
5 years (2017-01-13) 24.2

Is Psychemedics Corporation stock undervalued or overvalued?

Valuing Psychemedics Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Psychemedics Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Psychemedics Corporation's P/E ratio

Psychemedics Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 105x. In other words, Psychemedics Corporation shares trade at around 105x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Psychemedics Corporation's EBITDA

Psychemedics Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.5 million.

The EBITDA is a measure of a Psychemedics Corporation's overall financial performance and is widely used to measure a its profitability.

Psychemedics Corporation financials

Revenue TTM $23.8 million
Operating margin TTM 0.27%
Gross profit TTM $4.9 million
Return on assets TTM 0.17%
Return on equity TTM 3.06%
Profit margin 1.74%
Book value $2.53
Market capitalisation $41.9 million

TTM: trailing 12 months

Psychemedics Corporation share dividends

17%

Dividend payout ratio: 17.16% of net profits

Recently Psychemedics Corporation has paid out, on average, around 17.16% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.65% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Psychemedics Corporation shareholders could enjoy a 2.65% return on their shares, in the form of dividend payments. In Psychemedics Corporation's case, that would currently equate to about $0 per share.

While Psychemedics Corporation's payout ratio might seem low, this can signify that Psychemedics Corporation is investing more in its future growth.

Psychemedics Corporation's most recent dividend payout was on 29 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 16 December 2021 (the "ex-dividend date").

Have Psychemedics Corporation's shares ever split?

Psychemedics Corporation's shares were split on a 1:4 basis on 31 July 2002. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Psychemedics Corporation shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Psychemedics Corporation shares which in turn could have impacted Psychemedics Corporation's share price.

Psychemedics Corporation share price volatility

Over the last 12 months, Psychemedics Corporation's shares have ranged in value from as little as $4.9151 up to $8.8373. A popular way to gauge a stock's volatility is its "beta".

PMD.US volatility(beta: 0.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Psychemedics Corporation's is 0.7527. This would suggest that Psychemedics Corporation's shares are less volatile than average (for this exchange).

Psychemedics Corporation overview

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts. .

Frequently asked questions

What percentage of Psychemedics Corporation is owned by insiders or institutions?
Currently 18.166% of Psychemedics Corporation shares are held by insiders and 30.494% by institutions.
How many people work for Psychemedics Corporation?
Latest data suggests 138 work at Psychemedics Corporation.
When does the fiscal year end for Psychemedics Corporation?
Psychemedics Corporation's fiscal year ends in December.
Where is Psychemedics Corporation based?
Psychemedics Corporation's address is: 289 Great Road, Acton, MA, United States, 01720
What is Psychemedics Corporation's ISIN number?
Psychemedics Corporation's international securities identification number is: US7443752057
What is Psychemedics Corporation's CUSIP number?
Psychemedics Corporation's Committee on Uniform Securities Identification Procedures number is: 744375106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site